News
Academy
Publications
Media
Conferences
Columns
Resources
Webcasts
Subscribe

|Articles|March 5, 2018

Jamie Macdonald Appointed as the New CEO of PAREXEL

PAREXEL International Corporation announced the appointment of Jamie Macdonald as CEO effective March 15, 2018. The current CEO and co-founder of the company, Josef von Rickenbach will retire from his daily duties and continue as Chairman of the Board.

Read the full release

here

.

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Related Content

ACT Brief: Cross-Asset Site Partnerships, Vaccine Trial Standardization, and Ovarian Cancer Care Gaps

ByAndy Studna, Senior Editor

June 8th 2026

A Shot in the Arm to Traditional Vaccine Trial Strategy

June 5th 2026

SCOPE X: How AI Could Reshape the Sponsor-Site Relationship Over the Next Several Years

ByLiz Beatty,Andy Studna, Senior Editor

June 5th 2026

ACT Brief: Site-First Technology Strategy, AI Data Harmonization Architecture, and Obesity Trial Retention

ByAndy Studna, Senior Editor

June 5th 2026

© putilov_denis - © putilov_denis - stock.adobe.com

Patient Engagement Strategies in Anti-Obesity Medication Clinical Trials: Addressing Drop Out Rate and Improving Retention

ByMarcela Roy, MA, Lauren Crooks, MSc, Graham Ellis, MD, Alan Kott, MUDR, Dawie Wessels, MD, Elias Ketiar, MD, MRCP

June 4th 2026

Trending on Applied Clinical Trials Online

The Data Harmonization Imperative: How AI Is Solving Clinical Research's Biggest Bottleneck

SCOPE X: The COPD Case Study That Shows What AI Can Do for Enrollment

A Shot in the Arm to Traditional Vaccine Trial Strategy

SCOPE X: How AI Could Reshape the Sponsor-Site Relationship Over the Next Several Years

Patient Engagement Strategies in Anti-Obesity Medication Clinical Trials: Addressing Drop Out Rate and Improving Retention